Avior Wealth Management LLC Takes Position in iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA)

Avior Wealth Management LLC bought a new position in iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) during the third quarter, Holdings Channel reports. The fund bought 9,500 shares of the company’s stock, valued at approximately $234,000.

iShares Genomics Immunology and Healthcare ETF Stock Up 1.5 %

NYSEARCA:IDNA opened at $23.66 on Friday. The stock has a fifty day simple moving average of $24.37 and a 200 day simple moving average of $24.19. The firm has a market capitalization of $138.39 million, a price-to-earnings ratio of 2.29 and a beta of 1.14. iShares Genomics Immunology and Healthcare ETF has a 1-year low of $20.02 and a 1-year high of $25.80.

iShares Genomics Immunology and Healthcare ETF Profile

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.